Martin Wax, M.D. and Marc Nolet de Brauwere appointed to Board of Directors WAVRE, Belgium — 28 June 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the appointment of Martin Wax, M.D. and Marc Nolet de Brauwere to the Board of Directors. Dr […]
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2016-06-28 17:19:112017-10-17 08:01:29iSTAR Medical Strengthens Board with Two Senior Appointments
WAVRE, Belgium — 12 April 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the closing of a €10 million Series B equity financing. Existing shareholders including Capricorn Venture Partners and Walloon Region Investment Fund (SRIW) contributed to the round, which was joined by […]
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2016-04-12 16:51:512016-09-21 15:18:18iSTAR Medical Secures €10 Million Financing
ISNES, Belgium, April 27, 2015 /PRNewswire/ — iSTAR Medical SA, a Belgium ophthalmic device company, announced today the appointment of Michel Lussier as Chairman of the company’s Board of Directors.
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2015-04-27 16:48:322016-09-21 15:18:33iSTAR Medical Appoints Medical Device Executive Michel Lussier as Chairman of its Board of Directors
Isnes, Belgium (Oct 30, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that the first patient in its European multi-center clinical trial has been successfully implanted with the STARflo™ glaucoma drainage device.
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2014-10-30 16:45:172016-09-21 15:18:48iStar Medical Announces First Patient Implanted with STARflo™ Glaucoma Drainage Device in European Clinical Trial
Isnes, Belgium (July 16, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that Michel Vanbrabant has been appointed Chief Executive Officer and member of the Board of Directors.
https://www.istarmed.com/wp-content/uploads/2014/07/news_michel.png307920admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2014-07-16 16:41:352016-09-21 13:57:30iSTAR Medical appoints Michel Vanbrabant Chief Executive Officer
iSTAR Medical Strengthens Board with Two Senior Appointments
/in Press Releases /by adminMartin Wax, M.D. and Marc Nolet de Brauwere appointed to Board of Directors WAVRE, Belgium — 28 June 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the appointment of Martin Wax, M.D. and Marc Nolet de Brauwere to the Board of Directors. Dr […]
iSTAR Medical Secures €10 Million Financing
/in Press Releases /by adminWAVRE, Belgium — 12 April 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the closing of a €10 million Series B equity financing. Existing shareholders including Capricorn Venture Partners and Walloon Region Investment Fund (SRIW) contributed to the round, which was joined by […]
iSTAR Medical Appoints Medical Device Executive Michel Lussier as Chairman of its Board of Directors
/in Press Releases /by adminISNES, Belgium, April 27, 2015 /PRNewswire/ — iSTAR Medical SA, a Belgium ophthalmic device company, announced today the appointment of Michel Lussier as Chairman of the company’s Board of Directors.
iStar Medical Announces First Patient Implanted with STARflo™ Glaucoma Drainage Device in European Clinical Trial
/in Press Releases /by adminIsnes, Belgium (Oct 30, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that the first patient in its European multi-center clinical trial has been successfully implanted with the STARflo™ glaucoma drainage device.
iSTAR Medical appoints Michel Vanbrabant Chief Executive Officer
/in Press Releases /by adminIsnes, Belgium (July 16, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that Michel Vanbrabant has been appointed Chief Executive Officer and member of the Board of Directors.